[
  {
    "text": "past ten-years much has changed, and the original rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment has dropped precipitously by 15% since 2021 due to the following - 1. There is limited physician participation statewide with only 234 physicians and APRN’s having issued one or more cards in 2023. 2. The requirement of an in-person physician-patient visit to establish a bona-fide relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. This bill aims to improve access to safe, regulated medical cannabis for qualified patients in Hawaii by easing at least one",
    "number": 100.0,
    "filename": "HB302_TESTIMONY_HLT_01-29-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "much has changed, and the original rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment has dropped precipitously by 15% since 2021 due to the following - 1. There is limited physician participation statewide with only 234 physicians and APRN’s having issued one or more cards in 2023. 2. The requirement of an in-person physician-patient visit to establish a bona-fide relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. This bill aims to improve access to safe, regulated medical cannabis for qualified patients in Hawaii by easing at least one of the",
    "number": 300.0,
    "filename": "HB302_TESTIMONY_HLT_01-29-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "and the original rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment has dropped precipitously by 15% since 2021 due to the following - 1. There is limited physician participation statewide with only 234 physicians and APRN’s having issued one or more cards in 2023. 2. The requirement of an in-person physician-patient visit to establish a bona-fide relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. This bill aims to improve access to safe, regulated medical cannabis for qualified patients in Hawaii by easing at least one of the existing restrictions. Thank",
    "number": 38.5,
    "filename": "HB302_TESTIMONY_HLT_01-29-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "the legislature; (4) To establish and manage a secure and confidential database; (5) To fund public education as required by section 329D‑26; (6) To fund substance abuse prevention and education programs; [ and ] (7) To fund programs for the mitigation and abatement of nuisances relating to illegal cannabis and hemp products and chapter 329D ; and [ (7) ] (8) For any other expenditure necessary, consistent with this chapter and chapter 329D, to implement medical cannabis registry and regulation programs.\" SECTION 15 . There is appropriated out of the medical cannabis registry and regulation special fund the sum of $750,000 or so much thereof as may be necessary for fiscal year 2025-2026 and the same sum or so much thereof as may be necessary for fiscal year 2026-2027 for the department of the attorney general to enforce, and mitigate nuisances relating to, illegal cannabis and hemp products and chapter 329D, Hawaii Revised Statutes, and to establish, recruit, and hire the following positions: (1) Four full-time equivalent (4.0 FTE) investigator V positions; (2) One full-time equivalent (1.0 FTE) investigator IV position; and (3) One full-time equivalent (1.0 FTE) analyst position. The sums appropriated shall be expended by the attorney general for",
    "number": 750000.0,
    "filename": "HB302_CD1_.HTM.txt",
    "document_type": "document"
  },
  {
    "text": "medical provider\"; (4) Clarifying the conditions of use for the medical use of cannabis; (5) Authorizing the sale of hemp products and accessories to the medical use of cannabis at retail dispensing locations, except in the waiting room; (6) Establishing criminal penalties for the unlicensed operation of a medical cannabis dispensary beginning July 1, 2025, rather than January 1, 2027; (7) Authorizing expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances related to illegal cannabis and hemp products as well as medical cannabis dispensaries; (8) Inserting an appropriation of $750,000 from the Medical Cannabis Registry and Regulation Special Fund for the mitigation and abatement of nuisances related to illegal cannabis and hemp products and medical cannabis dispensaries, including the establishment of positions; (9) Prohibiting the cultivation of cannabis without a license issued by the Department of Health beginning January 1, 2028, rather than January 1, 2027, and deleting certain provisions relating to the maximum number of cannabis cultivator licenses and maximum plant canopy size; (10) Changing the effective date to July 1, 2025; and (11) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style. As affirmed by",
    "number": 750000.0,
    "filename": "HB302_CD1_CCR255_.htm.txt",
    "document_type": "committee_hearing"
  },
  {
    "text": "has changed, and the original rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment in December of 2024 hit a low of 29,882 participants (lowest participation since 2020). The high barriers to access include- 1. Limited physician participation statewide with only 237 physicians and APRN’s registered as of December 2024. 2. The requirement of an in-person physician-patient visit to establish a bona-ﬁde relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. LATE *Testimony submitted late may not be considered by the Committee for decision making purposes. \u0010\u0005\u0018 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. The dispensaries cannot compete with",
    "number": 100.0,
    "filename": "HB302_HD1_TESTIMONY_CPC_02-06-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "and the original rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment in December of 2024 hit a low of 29,882 participants (lowest participation since 2020). The high barriers to access include- 1. Limited physician participation statewide with only 237 physicians and APRN’s registered as of December 2024. 2. The requirement of an in-person physician-patient visit to establish a bona-ﬁde relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. LATE *Testimony submitted late may not be considered by the Committee for decision making purposes. \u0010\u0005\u0018 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. The dispensaries cannot compete with the sheer",
    "number": 300.0,
    "filename": "HB302_HD1_TESTIMONY_CPC_02-06-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "rules and regulations have had the unintended consequence of driving those seeking medical cannabis to the illicit black market. The program continues to struggle as enrollment in December of 2024 hit a low of 29,882 participants (lowest participation since 2020). The high barriers to access include- 1. Limited physician participation statewide with only 237 physicians and APRN’s registered as of December 2024. 2. The requirement of an in-person physician-patient visit to establish a bona-ﬁde relationship with a card issuer is burdensome. 3. The uninsured and uncontrolled cost of a medical cannabis card can range from $100 to $300 omit the $38.50 state fee, depending on the provider and island. 4. With limited physician participation, mandatory in-person visits, and high cost of entry, the program has become unaffordable and unattractive. LATE *Testimony submitted late may not be considered by the Committee for decision making purposes. \u0010\u0005\u0018 5. The next largest impacting factor has been the explosion of viable cannabis products that are being sold under the guise of hemp at businesses that allow immediate access as they do not require a medical card, offer online sales and in some cases delivery services. The dispensaries cannot compete with the sheer number of illegal",
    "number": 38.5,
    "filename": "HB302_HD1_TESTIMONY_CPC_02-06-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "also prevent patients from consulting with the practitioner of their choice. Many physicians are not trained in medical cannabis and the most knowledgeable medical cannabis practitioners may be on a different island. Hawaiʻi law should not impose unnecessary costs and burdens on medical cannabis patients that are not imposed on other medications. It should allow telemedicine for medical cannabis. 1 Omboni S, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health. 2022 Jan 4;1:7-35. doi: 10.20517/ch.2021.03. PMID: 35233563; PMCID: PMC7612439. WA , \\\\> 1“, .§\\ L /0 at \", ,l’/ \" $5 ' \"Ore r \\~~ \"\"3 /”/\\*~\\ Proposed Amendment: Allowing Medical Cannabis “Off-Label” Healthcare providers should be able to certify patients with any medical condition — or any debilitating medical condition — for the medical cannabis program. One-fifth of all prescriptions are “off-label,” or for a medical condition other than the one the FDA approved the medication for. Many prescriptions carry far more serious risks than medical cannabis. Opioid prescriptions cause more than 14,000 fatal overdose deaths per year,2 while cannabis has not been shown to have any lethal dose in humans.3 The sleeping pill Ambien now has a box warning",
    "number": 5.0,
    "filename": "HB302_HD2_TESTIMONY_HHS-CPN_03-19-25_.PDF.txt",
    "document_type": "testimony"
  },
  {
    "text": "that continue to meet the highest state standards for production. (2) Reconsider the amendment allowing for additional cultivation licenses [at this time]. The dispensary system has a demand issue not a supply issue. The demand for cannabis is not declining, but the demand to become a legal/329 cardholding patient is in decline. It is easier, cheaper [no 329 card required], and faster to get supply from the unregulated/illicit market. Within the dispensary system quality and variety of products continue to increase while prices are going down. For example, Big Island Grown’s RSO is available at the everyday low price of $20 per gram ensuring the most vulnerable patients in need have access to this therapeutic option, as well as $25-$30 quality eighths. Licensing fees have increased [300% for some] while patient numbers continue to decline. Currently there are not enough patient sales to support current licensees to even grow their own product. At least half of the licensees are [over] producing for the current market at partial production capacity. Some licensees are opting to purchase wholesale in lieu of turning on rooms due to operational costs and other considerations. There is already an overabundance of supply-industry is requesting wholesale language fix",
    "number": 20.0,
    "filename": "HB302_SD1_TESTIMONY_WAM-JDC_04-01-25_.PDF.txt",
    "document_type": "testimony"
  }
]